148 related articles for article (PubMed ID: 922745)
21. [Changes in prolactin plasma levels in relation to menopausal status in primary breast carcinoma].
Pavić S; Pavić Z
Med Pregl; 1995; 48(5-6):159-61. PubMed ID: 7565335
[TBL] [Abstract][Full Text] [Related]
22. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women.
Johansson H; Gandini S; Bonanni B; Mariette F; Guerrieri-Gonzaga A; Serrano D; Cassano E; Ramazzotto F; Baglietto L; Sandri MT; Decensi A
Breast Cancer Res Treat; 2008 Mar; 108(1):57-67. PubMed ID: 17468953
[TBL] [Abstract][Full Text] [Related]
23. Effects of reserpine on prolactin levels and incidence of breast cancer in postmenopausal women.
Ross RK; Paganini-Hill A; Krailo MD; Gerkins VR; Henderson BE; Pike MC
Cancer Res; 1984 Jul; 44(7):3106-8. PubMed ID: 6722826
[TBL] [Abstract][Full Text] [Related]
24. [Correlations between prolactin and somatotropic hormone in human breast cancer].
Larrad Jiménez A; Caballero Asensi A; Estévez Molina M
Rev Esp Oncol; 1980; 27(1):29-52. PubMed ID: 7209107
[TBL] [Abstract][Full Text] [Related]
25. A potential role of endogenous progesterone in modulation of GH, prolactin and thyrotrophin secretion during normal menstrual cycle.
Caufriez A; Leproult R; L'Hermite-Balériaux M; Moreno-Reyes R; Copinschi G
Clin Endocrinol (Oxf); 2009 Oct; 71(4):535-42. PubMed ID: 19222493
[TBL] [Abstract][Full Text] [Related]
26. High testosterone and low progesterone circulating levels in premenopausal patients with hyperplasia and cancer of the breast.
Secreto G; Recchione C; Fariselli G; Di Pietro S
Cancer Res; 1984 Feb; 44(2):841-4. PubMed ID: 6537901
[TBL] [Abstract][Full Text] [Related]
27. Mastectomy stimulates prolactin release in breast cancer patients.
Holtkamp W; Osterloh B; Rauschecker H; Nagel GA
Anticancer Res; 1986; 6(4):725-7. PubMed ID: 3752952
[TBL] [Abstract][Full Text] [Related]
28. [Prolactin and human cancer of the breast. I. Levels of correlation].
Cueto Ladrón de Guevara J; Villalba Moreno J; García Puche JL; Pedraza V
Rev Esp Oncol; 1985; 32(3):439-58. PubMed ID: 3870536
[TBL] [Abstract][Full Text] [Related]
29. The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.
Lowery AJ; Sweeney KJ; Molloy AP; Hennessy E; Curran C; Kerin MJ
BMC Cancer; 2008 Sep; 8():279. PubMed ID: 18826631
[TBL] [Abstract][Full Text] [Related]
30. Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones.
Rose DP; Cohen LA; Berke B; Boyar AP
J Natl Cancer Inst; 1987 Apr; 78(4):627-31. PubMed ID: 3470539
[TBL] [Abstract][Full Text] [Related]
31. Ultradian (12-hr) significant component in serum prolactin of healthy women and patients with fibrocystic mastopathy.
D'Allesandro B; Esposito V; Lo Iudice G; Cagnoni M; Tarquini B
Prog Clin Biol Res; 1987; 227B():281-4. PubMed ID: 3628338
[TBL] [Abstract][Full Text] [Related]
32. Timing of breast cancer surgery during the luteal menstrual phase may improve prognosis.
Lemon HM; Rodriguez-Sierra JF
Nebr Med J; 1996 Mar; 81(3):73-8. PubMed ID: 8907825
[TBL] [Abstract][Full Text] [Related]
33. Timing of breast cancer surgery during the luteal menstrual phase may improve prognosis.
Lemon HM; Rodriguez-Sierra JF
Nebr Med J; 1996 Apr; 81(4):110-5. PubMed ID: 8628449
[TBL] [Abstract][Full Text] [Related]
34. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.
Samojlik E; Veldhuis JD; Wells SA; Santen RJ
J Clin Invest; 1980 Mar; 65(3):602-12. PubMed ID: 6986409
[TBL] [Abstract][Full Text] [Related]
35. Hormonal profiles in women with breast cancer.
Zumoff B
Obstet Gynecol Clin North Am; 1994 Dec; 21(4):751-72. PubMed ID: 7731646
[TBL] [Abstract][Full Text] [Related]
36. Relationship between PRL levels and steroid receptors in breast cancer.
Marugo M; Fazzuoli L; Bernasconi D; Berta S; Giordano G
Anticancer Res; 1988; 8(4):819-23. PubMed ID: 3178171
[TBL] [Abstract][Full Text] [Related]
37. Circulating hormone levels in breast cancer patients. correlation with serum tumor markers and the clinical and biological features of the tumors.
Hernández L; Nuñez-Villarl MJ; Martínez-Arribas F; Pollán M; Schneider J
Anticancer Res; 2005; 25(1B):451-4. PubMed ID: 15816610
[TBL] [Abstract][Full Text] [Related]
38. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
[TBL] [Abstract][Full Text] [Related]
39. Evidence for increased non-ceruloplasmin copper in early-stage human breast cancer serum.
Dabek JT; Hyvönen-Dabek M; Härkönen M; Adlercreutz H
Nutr Cancer; 1992; 17(2):195-201. PubMed ID: 1584712
[TBL] [Abstract][Full Text] [Related]
40. Prolactin concentrations in patients with breast cancer.
Franks S; Ralphs DN; Seagroatt V; Jacobs HS
Br Med J; 1974 Nov; 4(5940):320-1. PubMed ID: 4434088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
